Houston-based Motif Neurotech develops a miniature brain pacemaker designed to precisely stimulate the brain. It restores healthy circuit activity to treat mental health disorders. The pea-sized implant, which goes in during a 20-minute outpatient procedure, has capabilities for at-home therapy.
Motif Neurotech says it should produce minimal side effects compared to drugs. Its lead product treats treatment-resistant depression (TRD), a form of major depressive disorder (MDD).
The company conducted the study in collaboration with researchers at Rice University, Baylor College of Medicine and UTHealth Houston. The human procedure took place at Baylor St. Luke’s Medical Center.